Healthcare entity
Every one of those 1 sits in a single category, telehealth. Laura Hernández is most often covered alongside FDA, which appears in 1 of these 1 story. Laura Hernández appears in 1 tracked Healthcare story from July 23, 2026. The tracked stories average 2 original sources each.
Last mentioned: Jul 23, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, telehealth. Laura Hernández is most often covered alongside FDA, which appears in 1 of these 1 story. Laura Hernández appears in 1 tracked Healthcare story from July 23, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Laura Hernández. Shared-story counts are live from our verified record — not editorial picks.
Clinicians and public health advocates are sounding the alarm over a potential ban on mail-order mifepristone, which now accounts for 30% of U.S. abortions. Over 400 state lawmakers cite rural hospital closures and transportation barriers as evidence that ending telehealth abortion would create a healthcare crisis for millions.
Source: Alanna Vagianos (us) · Alanna Vagianos (in)
Laura Hernández is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
